Curaleaf Holdings Inc T.CURA

Alternate Symbol(s): CURLF

Healthcare Cannabis

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.

TSX:CURA - Post by User

Curaleaf Holdings Inc > Schedule 3

<< Previous

Bullboard Posts

Next >>

Comment by Oldweedon May 03, 2024 4:22pm

54 Views

Post# 36022478

RE:RE:Schedule 3

blackspade799 wrote: One would think there has to be grounds for up-listing now that its no longer a scheduale 1 drug. BoJo said the major exchange called him April 30th after DEA SC3 announcement. CURA wrote to the major U.S. exchange 3mth ago, BoJo said the major U.S. exchange said they were happy to start a dialogue to more things forward. :)

Maybe, but as mentioned S3 will likely be finalized by October so it is more likely Safer will get pushed through before. If that is the case, that will trigger the uplist.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals